Jeff Geschwind, MD: Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD, researches glycolysis-targeting cancer drugs. His work addresses tumor metabolism, unlocking new treatment possibilities for aggressive cancers. https://www.linkedin.com/in/jeff-geschwind-037200174